Gui Liqiong, Niklason Laura E
Department of Anesthesiology, Yale University, New Haven, CT ; The Vascular Biology and Therapeutics Program, Yale University, New Haven, CT.
Department of Anesthesiology, Yale University, New Haven, CT ; The Vascular Biology and Therapeutics Program, Yale University, New Haven, CT ; Department of Biomedical Engineering, Yale University, New Haven, CT.
Curr Opin Chem Eng. 2014 Feb 1;3:68-74. doi: 10.1016/j.coche.2013.11.004.
Tissue and organ replacement is required when there are no alternative therapies available. Although vascular tissue engineering was originally developed to meet the clinical demands of small-diameter vascular conduits as bypass grafts, it has evolved into a highly advanced field where perfusable vasculatures are generated for implantation. Herein, we review several cutting-edge techniques that have led to implantable human blood vessels in clinical trials, the novel approaches that build complex perfusable microvascular networks in functional tissues, the use of stem cells to generate endothelial cells for vascularization, as well as the challenges in bringing vascular tissue engineering technologies into the clinics.
当没有其他替代疗法可用时,就需要进行组织和器官置换。尽管血管组织工程最初是为满足小直径血管导管作为旁路移植物的临床需求而开发的,但它已发展成为一个高度先进的领域,在此领域中可生成可灌注的脉管系统用于植入。在此,我们综述了几种已在临床试验中促成可植入人体血管的前沿技术、在功能组织中构建复杂可灌注微血管网络的新方法、利用干细胞生成用于血管化的内皮细胞,以及将血管组织工程技术引入临床所面临的挑战。